{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:45:18Z","timestamp":1759333518854},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1111\/dsu.12358","type":"journal-article","created":{"date-parts":[[2013,11,7]],"date-time":"2013-11-07T12:07:17Z","timestamp":1383826037000},"page":"1887-1894","source":"Crossref","is-referenced-by-count":12,"title":["Safety and Efficacy of One-Step Rehabilitation of Human Immunodeficiency Virus-Related Facial Lipoatrophy Using an Injectable Calcium Hydroxylapatite Dermal Filler"],"prefix":"10.1097","volume":"39","author":[{"given":"Raffaele","family":"Rauso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Curinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rusciani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Colella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Amore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianpaolo","family":"Tartaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-15-20210206","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1056\/NEJM199512073332303","article-title":"Safety, pharmakinetics and preliminary efficacy of ritonavir, and inhibitor of HIV-1 protease.","volume":"333","author":"Danner","year":"1995","journal-title":"N Eng J Med"},{"key":"R2-15-20210206","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199709113371101","article-title":"A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimetre or less.","volume":"337","author":"Hammer","year":"1997","journal-title":"N Eng J Med"},{"issue":"Suppl 2","key":"R3-15-20210206","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1086\/313854","article-title":"HIV protease inhibitor-related lipodystrophy syndrome.","volume":"30","author":"Carr","year":"2000","journal-title":"Clin Infect Dis"},{"key":"R4-15-20210206","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.qai.0000167478.28051.3a","article-title":"Redefining lipodystrophy syndrome: risks and impact on clinical decision making.","volume":"39","author":"Lichtenstein","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R5-15-20210206","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1742-1241.2007.01385.x","article-title":"Long-term complications of antiretroviral therapy: lipoatrophy.","volume":"61","author":"Waters","year":"2007","journal-title":"Int J Clin Pract"},{"issue":"7","key":"R6-15-20210206","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"R7-15-20210206","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","article-title":"Clinical assessment of HIV-associated lipodystrophy in an ambulatory population.","volume":"15","author":"Lichtenstein","year":"2001","journal-title":"AIDS"},{"key":"R8-15-20210206","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00126334-200209010-00007","article-title":"Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: the Swiss HIV Cohort study.","volume":"31","author":"Bernasconi","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R9-15-20210206","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1468-1293.2003.00159.x","article-title":"HIV lipodystrophy: prevalence, severity and correlates of risk in Australia.","volume":"4","author":"Miller","year":"2003","journal-title":"HIV Med"},{"key":"R10-15-20210206","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipida- emia, and diabetes mellitus: a cohort study.","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet"},{"key":"R11-15-20210206","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00002030-199903110-00004","article-title":"Redistribution of body fat in HIV- infected women undergoing combined antiretroviral therapy.","volume":"13","author":"Gervasoni","year":"1999","journal-title":"AIDS"},{"issue":"18","key":"R13-15-20210206","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1097\/00002030-200112070-00012","article-title":"Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy.","volume":"15","author":"Duran","year":"2001","journal-title":"AIDS"},{"issue":"2","key":"R14-15-20210206","first-page":"202","article-title":"A facial marker in facial wasting rehabilitation.","volume":"11","author":"Rauso","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"R15-15-20210206","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1089\/apc.2008.0230","article-title":"A systematic review of permanent and semipermanent dermal filler for HIV-associated lipoatrophy.","volume":"23","author":"Sturm","year":"2009","journal-title":"AIDS Patient Care STDS"},{"issue":"1","key":"R16-15-20210206","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s00266-011-9757-1","article-title":"Polyacrylamide gel for facial wasting rehabilitation: how many milliliters per session?","volume":"36","author":"Rauso","year":"2012","journal-title":"Aesthetic Plast Surg"},{"issue":"6","key":"R17-15-20210206","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00266-008-9189-8","article-title":"Long-term effect of polyalkylimide gel injections on severity of facial lipoatrophy and quality of life of HIV-positive patients.","volume":"32","author":"Karim","year":"2008","journal-title":"Aesthetic Plast Surg"},{"issue":"4","key":"R18-15-20210206","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1097\/SCS.0b013e31811eda9c","article-title":"Cheek augmentation with Bio-Alcamid in facial lipoatrophy in HIV seropositive patients.","volume":"19","author":"Honig","year":"2008","journal-title":"J Craniofac Surg"},{"key":"R19-15-20210206","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.2105\/AJPH.91.7.1060","article-title":"HIV in the United States at the turn of the century.","volume":"91","author":"Karon","year":"2001","journal-title":"Am J Public Health"},{"issue":"6","key":"R20-15-20210206","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1097\/PRS.0b013e3182131e38","article-title":"HIV-related lipoatrophy of the face: where should we have to fill?","volume":"127","author":"Rauso","year":"2011","journal-title":"Plast Recontr Surg"},{"key":"R21-15-20210206","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/135965350300800306","article-title":"Fat distribution and metabolic abnormalities in HIV infected patients on fistr combination antiretroviral therapy including stavudine or zidovudine: role of physical activity as a protective factor.","volume":"8","author":"Domingo","year":"2003","journal-title":"Antivir Ther"},{"key":"R22-15-20210206","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/00002030-199909100-00009","article-title":"A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long term nucleoside analogue therapy.","volume":"13","author":"Saint-Marc","year":"1999","journal-title":"AIDS"},{"key":"R23-15-20210206","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1097\/00002030-199910220-00035","article-title":"The effects of discontinuing stavudine therapy on clinical and metabolic abnormalities in patients suffering from lipodystrophy.","volume":"13","author":"Saint-Marc","year":"1999","journal-title":"AIDS"},{"key":"R24-15-20210206","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.qai.0000182230.47819.aa","article-title":"Fat distribution in men with HIV infection.","volume":"40","author":"Bacchetti","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R25-15-20210206","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/135965350100600102","article-title":"Antiretroviral therapy and the lipodystrophy syndrome.","volume":"6","author":"John","year":"2001","journal-title":"Antivir Ther"},{"key":"R26-15-20210206","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1097\/00002030-200411050-00005","article-title":"The effects of HIV protease inhibitors atazanavir and lopinavirritonavir on insulin sensitivity in HIV-seronegative healthy adults.","volume":"18","author":"Noor","year":"2004","journal-title":"AIDS"},{"key":"R27-15-20210206","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":"Efficacy and safety of tenofovir DF vs. stavudine in combination therapy in antiretroviral-naive patients: a 3 year randomized trial.","volume":"292","author":"Gallant","year":"2004","journal-title":"JAMA"},{"key":"R28-15-20210206","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(00)04056-3","article-title":"Risk of lipodystrophy in HIV-1 infected patients treated with protease inhibitors: a prospective cohort study.","volume":"357","author":"Martinez","year":"2001","journal-title":"Lancet"},{"key":"R29-15-20210206","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/jac\/dkh013","article-title":"Dyslipidaemia associated with antiretroviral therapy in HIV-infected patients.","volume":"53","author":"Calza","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"R30-15-20210206","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.PRS.0000128427.54445.63","article-title":"Treatment of facial fat atrophy related to treatment with protease inhibitor by autologous fat injection in patients with human immunodeficiency virus infec- tion.","volume":"114","author":"Serra-Renom","year":"2004","journal-title":"Plast Reconstr Surg"},{"key":"R31-15-20210206","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1097\/01.prs.0000267341.14550.a7","article-title":"Surgical algorithm for management of HIV lipodystrophy.","volume":"120","author":"Davison","year":"2007","journal-title":"Plast Reconstr Surg"},{"issue":"11","key":"R32-15-20210206","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1111\/j.1524-4725.2011.02131.x","article-title":"Polyacrylamide gel injection for treatment of human immunodeficiency virus-associated facial lipoatrophy: 18 months follow-up.","volume":"37","author":"Rauso","year":"2011","journal-title":"Dermatol Surg"},{"key":"R33-15-20210206","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/aid.2008.0230","article-title":"Four-year safety with polyacrylamide hydrogel to correct anti- retroviral-related facial lipoatrophy.","volume":"25","author":"Negredo","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"3","key":"R34-15-20210206","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000148252","article-title":"Hyaluronic acid new formulation: experience in HIV-associated facial lipoatrophy.","volume":"217","author":"Bechara","year":"2008","journal-title":"Dermatology"},{"key":"R37-15-20210206","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1001\/archfaci.6.4.234","article-title":"Evaluation of Radiance FN soft tissue filler for facial soft tissue augmentation.","volume":"6","author":"Tzikas","year":"2004","journal-title":"Arch Facial Plast Surg"},{"key":"R38-15-20210206","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/147641704100003048","article-title":"Clinical, histologic, and electron microscopic findings after injection of a calcium hydroxylapatite filler.","volume":"6","author":"Marmur","year":"2004","journal-title":"J Cosmet Laser Ther"},{"key":"R39-15-20210206","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jaad.2006.09.014","article-title":"Technique for calcium hydroxylapatite injection for correction of nasolabial fold depressions.","volume":"56","author":"Alam","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R40-15-20210206","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1097\/00042728-200806001-00017","article-title":"Radiographic and computed tomographic studies of calcium hydroxylapatite for treatment of HIV- associated facial lipoatrophy and correction of naso- labial folds.","volume":"34","author":"Carruthers","year":"2008","journal-title":"Dermatol Surg"},{"key":"R42-15-20210206","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0094-1298(20)32760-7","article-title":"Porous hydroxyapatite granules for alloplastic enhancement of the facial region.","volume":"27","author":"Hobar","year":"2000","journal-title":"Clin Plast Surg"},{"key":"R44-15-20210206","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1097\/00042728-200811000-00010","article-title":"Evaluation of injectable calcium hydroxylapatite for the treatment of facial lipoatrophy associated with human immunodeficiency virus.","volume":"34","author":"Carruthers","year":"2008","journal-title":"Dermatol Surg"},{"key":"R45-15-20210206","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1097\/00042728-200811000-00011","article-title":"Commentary: evaluation of injectable calcium hydroxylapatite for the treatment of facial lipoatrophy associated with human immunodeficiency virus.","volume":"34","author":"Jones","year":"2008","journal-title":"Dermatol Surg"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1111\/dsu.12358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T07:55:01Z","timestamp":1688630101000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00042728-201312000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1111\/dsu.12358","relation":{},"ISSN":["1076-0512"],"issn-type":[{"value":"1076-0512","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}